FDA approves ripretinib for advanced gastrointestinal stromal tumour
The Food and Drug Administration (FDA) approved ripretinib, for adult patients with advanced gastrointestinal stromal…
Browsing: advanced gastrointestinal stromal tumour
The Food and Drug Administration (FDA) approved ripretinib, for adult patients with advanced gastrointestinal stromal…